Abstract
Aspirin, aspirin plus dipyridamole, or clopidogrel often is used to prevent recurrent stroke. In the double-blind randomized PRoFESS trial, more than 20,000 clinically stable patients (age, 50) with recent ischemic strokes received either a fixed combination of aspirin (25 mg) plus extended-release dipyridamole (200 mg) twice daily or clopidogrel (75 mg) once daily. The study was sponsored by the maker of the aspirin/dipyridamole …
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
